{"id":"W4409285391","doi":"10.1182/bloodadvances.2024014523","title":"Comparative efficacy of Bruton tyrosine kinase inhibitors in high-risk relapsed/refractory CLL: a network meta-analysis","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"Air Liquide (Canada)","funders":"Cilag; Grifols; BeiGene; MEI Pharma; TG Therapeutics; Gilead Sciences; AstraZeneca; Eli Lilly and Company","keywords":"Ibrutinib; Hazard ratio; Internal medicine; Medicine; Oncology; Chronic lymphocytic leukemia; Bendamustine; Idelalisib; Confidence interval; Leukemia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02331202,0.002881503,0.01329186,0.002936789,0.0004215092,0.002945387,0.002160411,0.002172054,0.00390772],"category_scores_gemma":[0.02586863,0.001386311,0.04224449,0.003365083,0.0006084783,0.001679926,0.001702284,0.002629323,0.0003484428],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001304507,"about_ca_system_score_gemma":0.000864359,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003827053,"about_ca_topic_score_gemma":0.00413293,"domain_scores_codex":[0.9805954,0.01479513,0.001475172,0.001982598,0.0007947909,0.000356946],"domain_scores_gemma":[0.9787478,0.01648137,0.002127691,0.001389324,0.0008158615,0.0004378109],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.01341647,0.00002861295,0.007744046,0.00927444,0.9647825,0.00005460526,0.00002245419,0.001677481,0.0001891815,0.00009522445,0.0003479262,0.002367099],"study_design_scores_gemma":[0.003022019,0.0003617775,0.005432001,0.0006307092,0.9878089,0.00004355991,0.00001978921,0.00170372,0.0001010841,0.0003320636,0.0005227582,0.00002148902],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.2302084,0.7457443,0.01073287,0.001590652,0.001265263,0.0008884054,0.006697488,0.0003406823,0.002531954],"genre_scores_gemma":[0.9629337,0.02988138,0.002907164,0.0007784776,0.0002828794,0.0006416211,0.001960838,0.00008346809,0.0005305866],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.02331202,"threshold_uncertainty_score":0.1232872,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03625451264315024,"score_gpt":0.3441972454570205,"score_spread":0.3079427328138703,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}